Innate Pharma : Assemblée Générale 2021 a Distance
12 mai 2021 01h00 HE
|
INNATE PHARMA
Marseille, France, 12 mai 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a publié aujourd’hui au Bulletin des...
Innate Pharma Virtual 2021 Annual General Meeting
12 mai 2021 01h00 HE
|
INNATE PHARMA
Marseille, France, May 12, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) has published the convening notice to the...
Information Financiere du Premier Trimestre 2021
11 mai 2021 01h00 HE
|
INNATE PHARMA
Marseille, France, 11 mai 2021 (GLOBE NEWSWIRE) -- Progression de l’essai TELLOMAK : lacutamab a démontré un signal préliminaire positif permettant à la cohorte de patients présentant un mycosis...
Innate Pharma First Quarter 2021 Report
11 mai 2021 01h00 HE
|
INNATE PHARMA
Marseille, France, May 11, 2021 (GLOBE NEWSWIRE) -- Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signal Company’s...
Innate Pharma First Quarter 2021 Report
11 mai 2021 01h00 HE
|
INNATE PHARMA
Lacutamab TELLOMAK trial progresses as KIR3DL2-expressing mycosis fungoides cohort advances to Stage 2 after positive early signalCompany’s first NK cell engager selected by Sanofi as drug candidate...
Innate Pharma Organise une Conférence Téléphonique et un Webcast pour son Information Financière du Premier Trimestre 2021
04 mai 2021 01h00 HE
|
INNATE PHARMA
Marseille, France, 04 mai 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») a annoncé aujourd'hui qu'elle...
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
04 mai 2021 01h00 HE
|
INNATE PHARMA
Marseille, France, May 04, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold...
Innate Pharma Announces Conference Call and Webcast for 2021 First Quarter Business Update
04 mai 2021 01h00 HE
|
INNATE PHARMA
MARSEILLE, France, May 04, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”), today announced that the Company will hold...
Innate Pharma Files Its 2020 Universal Registration Document (Document D’enregistrement Universel) and 2020 Annual Report on Form 20-F
28 avr. 2021 01h00 HE
|
INNATE PHARMA
MARSEILLE, France, April 28, 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the filing of its 2020...
Innate Pharma Publie son Document d'Enregistrement Universel 2020 et son Rapport Annuel 2020 sur « Form 20-F »
28 avr. 2021 01h00 HE
|
INNATE PHARMA
Marseille, France, 28 avr. 2021 (GLOBE NEWSWIRE) -- Innate Pharma SA (Euronext Paris : IPH – ISIN : FR0010331421 ; Nasdaq : IPHA) (« Innate » ou la « Société ») annonce que son Document...